A detailed history of Dagco, Inc. transactions in Danaher Corp stock. As of the latest transaction made, Dagco, Inc. holds 2,465 shares of DHR stock, worth $609,298. This represents 0.27% of its overall portfolio holdings.

Number of Shares
2,465
Previous 2,465 -0.0%
Holding current value
$609,298
Previous $615,000 -0.0%
% of portfolio
0.27%
Previous 0.28%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$224.58 - $256.19 $553,589 - $631,508
2,465 New
2,465 $615,000
Q3 2023

Dec 07, 2023

BUY
$233.08 - $265.59 $2 Million - $2.28 Million
8,570 Added 287.97%
11,546 $2.86 Million
Q1 2023

May 05, 2023

SELL
$239.75 - $277.0 $11,987 - $13,850
-50 Reduced 1.65%
2,976 $750,000
Q3 2022

Nov 01, 2022

SELL
$247.06 - $1507.4 $18,529 - $113,055
-75 Reduced 2.42%
3,026 $782,000
Q2 2022

Jul 28, 2022

SELL
$237.11 - $299.66 $5,927 - $7,491
-25 Reduced 0.8%
3,101 $786,000
Q1 2022

Apr 21, 2022

BUY
$257.27 - $315.76 $23,154 - $28,418
90 Added 2.96%
3,126 $854,000
Q3 2021

Nov 01, 2021

SELL
$272.21 - $332.43 $31,304 - $38,229
-115 Reduced 3.65%
3,036 $924,000
Q2 2021

Jul 12, 2021

SELL
$225.08 - $271.69 $5,627 - $6,792
-25 Reduced 0.79%
3,151 $846,000
Q1 2021

Apr 28, 2021

BUY
$212.38 - $245.9 $44,812 - $51,884
211 Added 7.12%
3,176 $715,000
Q3 2020

Oct 19, 2020

SELL
$177.16 - $215.33 $8,858 - $10,766
-50 Reduced 1.66%
2,965 $638,000
Q2 2020

Jul 27, 2020

BUY
$128.7 - $176.83 $14,800 - $20,335
115 Added 3.97%
3,015 $533,000
Q4 2019

Feb 06, 2020

BUY
$133.47 - $153.48 $30,030 - $34,533
225 Added 8.41%
2,900 $445,000
Q1 2019

May 13, 2019

SELL
$97.62 - $132.29 $12,202 - $16,536
-125 Reduced 4.46%
2,675 $353,000
Q4 2018

Feb 14, 2019

BUY
$94.85 - $109.54 $265,580 - $306,712
2,800 New
2,800 $289,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $180B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Dagco, Inc. Portfolio

Follow Dagco, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dagco, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Dagco, Inc. with notifications on news.